Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-05-2022 | Infliximab | Case report

Adalimumab/infliximab

Paradoxical reaction in the form of bullous pemphigoid: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Otani Y, et al. Pustular psoriasis associated with bullous pemphigoid with fluctuating anti-BP180 antibody titre according to the condition of pustular lesions. European Journal of Dermatology 31: 107-109, No. 1, Jan 2021. Available from: URL: https://rd.springer.com/journal/40699 Otani Y, et al. Pustular psoriasis associated with bullous pemphigoid with fluctuating anti-BP180 antibody titre according to the condition of pustular lesions. European Journal of Dermatology 31: 107-109, No. 1, Jan 2021. Available from: URL: https://​rd.​springer.​com/​journal/​40699
Metadata
Title
Adalimumab/infliximab
Paradoxical reaction in the form of bullous pemphigoid: case report
Publication date
01-05-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-15750-5

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Covid-19-vaccine

Case report

Aspirin

Case report

Acalabrutinib